🔬

DIVISLAB

📈 Rallies After Analyst Upgrade!

What’s going on? Shares of

surged about 2% today after receiving an upgrade from HSBC, amidst broad market jitters over U.S. tariffs and trade uncertainties. Why it matters: A strong upgrade from a top global brokerage signals positive analyst sentiment, potentially attracting more institutional inflows. As a leading pharma ingredient manufacturer, is well-positioned to benefit from rising global demand and India-centric supply chain shifts. Market vibe: The broader market is treading water amid looming tariff actions—but pockets of sector-specific strength are shining through. While financials and private banks remain steady, pharma is emerging as a defensive outperformer.